We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.37%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.02B
AUM Growth
-$31.8M
(-0.79%)
Cap. Flow
-$14.7M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
55.91%
Holding
627
New
130
Increased
130
Reduced
70
Closed
208
Avg Time Held Equity + Options
3.7
quarters
Top 10 Avg Time Held Equity + Options
1.3
quarters
Top 20 Avg Time Held Equity + Options
1.5
quarters
Avg Time Held Equity only
3.8
quarters
Top 10 Avg Time Held Equity only
1.3
quarters
Top 20 Avg Time Held Equity only
1.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Discover Financial Services
DFS
|
+$191M |
| 2 |
Smartsheet Inc.
SMAR
|
+$188M |
| 3 |
Frontier Communications
FYBR
|
+$124M |
| 4 |
Summit Materials, Inc. Class A Common Stock
SUM
|
+$95M |
| 5 |
Altair Engineering Inc
ALTR
|
+$92.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CATALENT, INC.
CTLT
|
+$234M |
| 2 |
Marathon Oil Corporation
MRO
|
+$222M |
| 3 |
Stericycle Inc
SRCL
|
+$172M |
| 4 |
Axonics, Inc. Common Stock
AXNX
|
+$150M |
| 5 |
Perficient Inc
PRFT
|
+$79.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.76% |
| 2 | Energy | 15.79% |
| 3 | Communication Services | 7.77% |
| 4 | Consumer Staples | 7.72% |
| 5 | Financials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
e.l.f. Beauty
ELF
$6.45B
| $942K | 0.02% |
+7,500
| New | +$900K |
2024 Q4
0 quarters
|
|
227
Ultragenyx Pharmaceutical
RARE
$1.53B
| $937K | 0.02% |
22,284
+1,015
| +5% | +$50.4K |
2022 Q4
8 quarters
|
|
228
Cooper Companies
COO
$10.3B
| $930K | 0.02% |
10,112
+1,826
| +22% | +$186K |
2024 Q1
3 quarters
|
|
229
X4 Pharmaceuticals
XFOR
$289M
| $928K | 0.02% |
42,145
-9,500
| -18% | -$151K |
2023 Q2
6 quarters
|
|
230
Schrodinger
SDGR
$2.04B
| $905K | 0.02% |
46,914
+18,598
| +66% | +$361K |
2022 Q1
11 quarters
|
|
231
Disc Medicine
IRON
$2.38B
| $904K | 0.02% |
14,257
-426
| -3% | -$24.6K |
2023 Q1
7 quarters
|
|
232
Xencor
XNCR
$1.83B
| $897K | 0.02% |
39,040
+7,040
| +22% | +$162K |
2024 Q3
1 quarter
|
|
233
enVVeno Medical
NVNO
$6.08M
| $894K | 0.02% |
8,458
| – | – |
2022 Q1
11 quarters
|
|
234
Silence Therapeutics
SLN
$613M
| $887K | 0.02% |
128,990
+43,289
| +51% | +$559K |
2022 Q2
10 quarters
|
|
235
Ovid Therapeutics
OVID
$480M
| $881K | 0.02% |
943,416
+315,126
| +50% | +$353K |
2023 Q2
6 quarters
|
|
236
Viridian Therapeutics
VRDN
$2.11B
| $855K | 0.02% |
+44,600
| New | +$970K |
2024 Q4
0 quarters
|
|
237
Strategy Inc
MSTR
$61.5B
| $851K | 0.02% |
+2,937
| New | +$884K |
2024 Q4
0 quarters
|
|
238
UWM Holdings
UWMC
$373M
| $839K | 0.02% |
+143,000
| New | +$931K |
2024 Q4
0 quarters
|
|
|
YARW
239
Yarrow Bioscience
YARW
$166M
| $823K | 0.02% |
+4,916
| New | +$643K |
2024 Q4
0 quarters
|
|
240
On Holding
ONON
$11.7B
| $822K | 0.02% |
+15,000
| New | +$795K |
2024 Q4
0 quarters
|
|
241
Zoom
ZM
$28.5B
| $816K | 0.02% |
+10,000
| New | +$786K |
2024 Q4
0 quarters
|
|
242
Keros Therapeutics
KROS
$237M
| $806K | 0.02% |
50,897
+26,145
| +106% | +$1.36M |
2022 Q1
11 quarters
|
|
243
PUT
Harley-Davidson
HOG
$2.8B
| $805K | 0.02% |
235,000
| – | – |
2023 Q3
5 quarters
|
|
244
Magnite
MGNI
$3.64B
| $796K | 0.02% |
+50,000
| New | +$734K |
2024 Q4
0 quarters
|
|
245
DELISTED
Terns Pharmaceuticals
TERN
| $777K | 0.02% |
140,300
+92,300
| +192% | +$625K |
2024 Q3
1 quarter
|
|
246
PUT
Transocean
RIG
$6.15B
| $757K | 0.02% |
803,400
+400,000
| +99% | +$1.66M |
2018 Q2
26 quarters
|
|
247
Neurogene
NGNE
$528M
| $748K | 0.02% |
32,734
+23,907
| +271% | +$890K |
2024 Q2
2 quarters
|
|
248
Boston Scientific
BSX
$61.9B
| $744K | 0.02% |
8,334
+1,507
| +22% | +$133K |
2022 Q1
11 quarters
|
|
249
Larimar Therapeutics
LRMR
$277M
| $730K | 0.02% |
188,543
-14,240
| -7% | -$94K |
2022 Q4
8 quarters
|
|
250
Edwards Lifesciences
EW
$49.1B
| $723K | 0.02% |
9,760
+2,760
| +39% | +$193K |
2024 Q3
1 quarter
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q4 2024 Portfolio in Review
As of Q4 2024, UBS O'Connor held 627 positions worth $4.02B, down 0.79% from $4.05B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
UBS O'Connor's Q4 2024 filing shows 130 new, 130 increased, 70 reduced and 208 closed positions. Its largest new stake was Discover Financial Services: 1,166,698 shares worth $202M. The largest sale was CATALENT, INC., an estimated $234M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 20% a quarter earlier, followed by Energy and Communication Services.
- UBS O'Connor's largest Q4 2024 buy was Discover Financial Services: 1,166,698 shares worth $202M.
- UBS O'Connor added most to Smartsheet Inc. in Q4 2024, an estimated $188M increase.
- UBS O'Connor's biggest Q4 2024 reduction was US Steel, cutting an estimated $62.2M.
- UBS O'Connor fully exited CATALENT, INC. in Q4 2024, selling an estimated $234M.
- UBS O'Connor's ten largest holdings make up 56% of its $4.02B portfolio in Q4 2024.
- UBS O'Connor opened 130 new positions and closed 208 in Q4 2024.
- UBS O'Connor's portfolio value fell 0.79% quarter-over-quarter to $4.02B.
Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.